Cancer risk among lung transplant recipients with cystic fibrosis

Journal of Cystic Fibrosis

Volumn 16, Issue 1, 2017, Pages 91-97

  Fink, Aliza K ^a   Yanik, Elizabeth L ^b   Marshall, Bruce C ^a   Wilschanski, Michael ^c   Lynch, Charles F ^d   Austin, April A ^e   Copeland, Glenn ^f   Safaeian, Mahboobeh ^b   Engels, Eric A ^b  

^a CYSTIC FIBROSIS FOUNDATION   (United States)

^b NATIONAL CANCER INSTITUTE   (United States)

^c HADASSAH HEBREW UNIVERSITY MEDICAL CENTER   (Israel)

^d UNIVERSITY OF IOWA   (United States)

^e NEW YORK STATE DEPARTMENT OF HEALTH   (United States)

^f MICHIGAN DEPARTMENT OF HEALTH AND HUMAN SERVICES   (United States)

Author keywords

Cancer; Transplant

Indexed keywords

ACUTE MONOCYTIC LEUKEMIA; ADOLESCENT; ADULT; AGED; ARTICLE; CANCER INCIDENCE; CANCER REGISTRY; CANCER RISK; CHILD; COLORECTAL CANCER; CONTROLLED STUDY; CYSTIC FIBROSIS; DIFFUSE LARGE B CELL LYMPHOMA; ESOPHAGUS CANCER; FEMALE; FOLLOW UP; GRAFT RECIPIENT; GRAFT SURVIVAL; HUMAN; INFANT; INTRAHEPATIC BILE DUCT; KAPOSI SARCOMA; LUNG CANCER; LUNG TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; MIDDLE AGED; NONHODGKIN LYMPHOMA; SKIN CANCER; STANDARDIZED INCIDENCE RATIO; ADVERSE DRUG REACTION; COLORECTAL TUMOR; INCIDENCE; PROCEDURES; REGISTER; RISK ASSESSMENT; STATISTICS AND NUMERICAL DATA; UNITED STATES;

ADULT; COLORECTAL NEOPLASMS; CYSTIC FIBROSIS; FEMALE; HUMANS; INCIDENCE; LONG TERM ADVERSE EFFECTS; LUNG TRANSPLANTATION; MALE; MIDDLE AGED; REGISTRIES; RISK ASSESSMENT; TRANSPLANT RECIPIENTS; UNITED STATES;

EID: 84992745663     PISSN: 15691993     EISSN: 18735010     Source Type: Journal    
DOI: 10.1016/j.jcf.2016.07.011     Document Type: Article

References (23)

1. [1] Farrell, P.M., Rosenstein, B.J., White, T.B., Accurso, F.J., Castellani, C., Cutting, G.R., et al. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic Fibrosis Foundation consensus report. J Pediatr 153:2 (2008), S4–S14.
2. [2] Cystic Fibrosis Foundation/Foundation CF. Annual data report to the center directors. 2014, Cystic Fibrosis Foundation, Bethesda, MD.
3. [3] McIntosh, J.C., Schoumacher, R.A., Tiller, R.E., Pancreatic adenocarcinoma in a patient with cystic fibrosis. Am J Med, 85(4), 1988, 592.
4. [4] Tedesco, F.J., Brown, R., Schuman, B.M., Pancreatic carcinoma in a patient with cystic fibrosis. Gastrointest Endosc 32:1 (1986), 25–26.
5. [5] Roberts, J.A., Tullett, W.M., Thomas, J.S., Galloway, D., Stack, B.H., Bowel adenocarcinoma in a patient with cystic fibrosis. Scott Med J, 31(2), 1986, 109.
6. [6] Redington, A.N., Spring, R., Batten, J.C., Adenocarcinoma of the ileum presenting as non-traumatic clostridial myonecrosis in cystic fibrosis. Br Med J (Clin Res Ed) 290:6485 (1985), 1871–1872.
7. [7] Abdul-Karim, F.W., King, T.A., Dahms, B.B., Gauderer, M.W., Boat, T.F., Carcinoma of extrahepatic biliary system in an adult with cystic fibrosis. Gastroenterology 82:4 (1982), 758–762.
8. [8] Neglia, J.P., FitzSimmons, S.C., Maisonneuve, P., Schoni, M.H., Schoni-Affolter, F., Corey, M., et al. The risk of cancer among patients with cystic fibrosis. Cystic fibrosis and cancer study group. N Engl J Med 332:8 (1995), 494–499.
9. [9] Neglia, J.P., Wielinski, C.L., Warwick, W.J., Cancer risk among patients with cystic fibrosis. J Pediatr 119:5 (1991), 764–766.
10. [10] Maisonneuve, P., FitzSimmons, S.C., Neglia, J.P., Campbell, P.W. III, Lowenfels, A.B., Cancer risk in nontransplanted and transplanted cystic fibrosis patients: a 10-year study. J Natl Cancer Inst 95:5 (2003), 381–387.
11. [11] Maisonneuve, P., Marshall, B.C., Knapp, E.A., Lowenfels, A.B., Cancer risk in cystic fibrosis: a 20-year nationwide study from the United States. J Natl Cancer Inst 105:2 (2013), 122–129.
12. [12] Grulich, A.E., van Leeuwen, M.T., Falster, M.O., Vajdic, C.M., Incidence of cancers in people with HIV/AIDS compared with immunosuppressed transplant recipients: a meta-analysis. Lancet 370:9581 (2007), 59–67.
13. [13] Engels, E.A., Pfeiffer, R.M., Fraumeni, J.F. Jr., Kasiske, B.L., Israni, A.K., Snyder, J.J., et al. Spectrum of cancer risk among US solid organ transplant recipients. JAMA 306:17 (2011), 1891–1901.
14. [14] Safaeian, M., Robbins, H.A., Berndt, S.I., Lynch, C.F., Fraumeni, J.F. Jr., Engels, E.A., Risk of colorectal cancer after solid organ transplantation in the United States. Am J Transplant 16:3 (2016), 960–967.
15. [15] Screening for colorectal cancer: recommendation and rationale. Ann Intern Med, 137(2), 2002, 129–131.
16. [16] Hall, E.C., Pfeiffer, R.M., Segev, D.L., Engels, E.A., Cumulative incidence of cancer after solid organ transplantation. Cancer 119:12 (2013), 2300–2308.
17. [17] Lin, D.Y., Non-parametric inference for cumulative incidence functions in competing risks studies. Stat Med 16:8 (1997), 901–910.
18. [18] Meyer, K.C., Francois, M.L., Thomas, H.K., Radford, K.L., Hawes, D.S., Mack, T.L., et al. Colon Cancer in lung transplant recipients with CF: increased risk and results of screening. J Cyst Fibros 10:5 (2011), 366–369.
19. [19] Johannesson, M., Askling, J., Montgomery, S.M., Ekbom, A., Bahmanyar, S., Cancer risk among patients with cystic fibrosis and their first-degree relatives. Int J Cancer 125:12 (2009), 2953–2956.
20. [20] Than, B.L., Linnekamp, J.F., Starr, T.K., Largaespada, D.A., Rod, A., Zhang, Y., et al. CFTR is a tumor suppressor gene in murine and human intestinal cancer. Oncogene, 2016.
21. [21] Ahn, J., Sinha, R., Pei, Z., Dominianni, C., Wu, J., Shi, J., et al. Human gut microbiome and risk for colorectal cancer. J Natl Cancer Inst 105:24 (2013), 1907–1911.
22. [22] Gory, I., Brown, G., Wilson, J., Kemp, W., Paul, E., Roberts, S.K., Increased risk of colorectal neoplasia in adult patients with cystic fibrosis: a matched case–control study. Scand J Gastroenterol 49:10 (2014), 1230–1236.
23. [23] Billings, J.L., Dunitz, J.M., McAllister, S., Herzog, T., Bobr, A., Khoruts, A., Early colon screening of adult patients with cystic fibrosis reveals high incidence of adenomatous colon polyps. J Clin Gastroenterol 48:9 (2014), e85–e88.